Structured facts
{
"code": "A",
"date": "2026-05-21",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on May 21, 2027; however, delivery of the shares is deferred until the earlier of (a) the date of the director\u0027s separation from service to Karyopharm Therapeutics Inc. and (b) a change-in-control event.",
"F2": "Amounts reported in this Form 4 reflect the one-for fifteen reverse stock split effected by Karyopharm Therapeutics Inc. on February 25, 2025."
},
"owners": [
{
"cik": "0001291963",
"name": "Greene Barry E",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "16415",
"price": "0",
"row": 1,
"rule_10b5_1": "false",
"security": "Common Stock",
"shares": "15508",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}